Member Info for cd27idw

I'm starting to suspect that Oisin and Martin thrive on the pain, and are happy for this to drag out interminally. Us little fishes might be happy to trundle along in the expectation of some gravy when the main course arrives, but the lack of communication is excrutiating. Best get a life in the meantime.

New corporate action today:

Description

IQE Plc Retail Offer - Update

IQE plc have issued an update regarding their recent Retail Offer. New shares were initially expected to be issued on 20th May 2026. However, the fund raising was conditional upon MACOM (who participated in the Fundraising and who are mentioned in the company's announcement to the Stock Exchange concerning the results of the Retail Offer, which you can access via the link below) obtaining prior clearance for its subscription under the National Security and Investment Act 2021. Completion of the Fundraising is therefore now expected to occur in early June 2026, with 11 August 2026 being announced the latest date for Admission.

https://www.londonstockexchange.com/news-article/IQE/iqe-plc-results-of-placing-and-retail-offer/17566046

Accounts will be updated once we receive the new shares from the registrar.

My original ii communication:

Description

IQE plc

Price per new share: GBP0.198 (19.8 pence)

Expected issue date: 20th May 2026

IQE plc has announced its intention to raise additional capital by way of a short notice Retail Offer. Your options are;

Option 1: Do nothing (Default)

I've been hanging in here since 2017, with a number of adds. Still down, but still believing.

I asked the question of Google AI: is puretech a buy

The consensus among market analysts is a Strong Buy for PureTech Health (LSE: PRTC). The stock trades around 131p, with a consensus 12-month target price of 506p to 508p, representing a potential upside of over 280%.

Key Investment Drivers

Pipeline Catalysts: Its wholly-owned subsidiary, Celea Therapeutics, is showcasing promising Phase 3-ready data for its idiopathic pulmonary fibrosis (IPF) drug, deupirfenidone, at the American Thoracic Society International Conference.

Proven Business Model:

PureTech operates an innovative biopharma hub structure. It discovers and creates "Founded Entities" (such as the recently upsized Nasdaq IPO of Seaport Therapeutics), allowing it to unlock massive equity value while advancing treatments capital-efficiently.

Insider Confidence:

Non-executive directors and board chairs executed multiple on-market share purchases late last year, signaling strong internal alignment and value conviction.

Key Risks & Changes

Nasdaq Delisting:

PureTech announced plans to voluntarily delist from the Nasdaq to focus its trading and liquidity entirely on the London Stock Exchange. US investors will have to trade it via the LSE.

Financial Volatility:

Like most clinical-stage biotechs, revenues are highly irregular. Trailing revenues sat at £4.66m for 2025, down 3.5% from 2024, with negative EPS due to heavy R&D reinvestment.I

"On the RR comparison, there's was a Right Issue as well..."

That's what I was referring to. 32p for existing shareholders, vs 60p-70p market price. Whether or not IQE will hit all time high market caps like RR is another matter. You pays your money, you takes your chance...

"If price stays up over 40p the board have raised at a far too low price."

Just like Rolls-Royce set their cash raising price at 32p when the share price was 67p+. And now...

Hopefully the burgeoning market will be IQEs saviour.

From dear old Gemini, confusion reigns tomorrow will be definitive re The State Gazette (Ireland). Or maybe it won't. (Item 3 should bring about a great gnashing of teeth)

Gemini said

As of Thursday, March 12, 2026, the status of San Leon Energy PLC remains in a state of high-stakes "verification limbo."

While a legal judgment was delivered earlier this year paving the way for liquidation, the formal winding-up order has faced a dramatic last-minute delay. Here is the breakdown of the situation as it stands before tomorrow’s records are released.

1. The "Houdini Act" (Current Court Status)

On Monday, March 9, 2026, the High Court of Ireland was expected to finalize the winding-up petition brought by Brightwaters Energy. However, the order has not yet been executed or advertised.

The Adjournment: Reports from court proceedings indicate that San Leon’s legal team presented evidence of a pending settlement (likely involving a $16.5 million payment from third-party funders).

The Stay: The judge appears to have granted a brief stay of execution (likely 7 to 14 days) to allow these funds to clear. This means the company is currently "Alive and Trading," though its board remains under intense pressure.

The Liquidator-Elect: Interpath Advisory (Kieran Wallace) remains the designated liquidator should the settlement fail, but they have confirmed they have not been officially appointed as of today.

2. The Final Truth: Iris Oifigiúil (The State Gazette)

Under Irish law, once a winding-up order is formally made, it must be published in the Iris Oifigiúil.

Tomorrow’s Edition (Friday, March 13): This is the critical date. If the winding-up order was finalized earlier this week despite the adjournment rumors, it will appear in tomorrow’s publication.

If it is NOT listed: It confirms that the adjournment holds and the company has successfully bought more time to secure the refinancing needed to pay Brightwaters.

3. Recent High Court Victory

In a separate but notable twist, San Leon was awarded €16 million in damages on March 11, 2026, against Tri Ri Asset Management (TRAM).

The court ruled in favor of San Leon after TRAM failed to defend a lawsuit regarding a reneged investment deal.

While this provides a massive legal "win," the immediate challenge remains liquidity: San Leon needs cash-in-hand to stop the Brightwaters petition, and a damages award can take time to collect.

Anyone on this board missing Alaric? Long term spikey individual, nowhere to be seen. Wonder if he's in good health, or has just given up on SLE. His barbs would be more welcome than the general nastiness which is prevailing latterly.

Anyhoo. The real tension (IMHO) is what form the recent funding has taken, and it's impact on the share issue. Comments have been made (with no substantiation) of debts being called in, possibly leaving SLE in a flush, or reasonably so, position, such that the company accounts could be made up to date, which they apparently already have been. Presumably access to this 500m Eurobond was dependant on the company showing itself to be financially viable.

Obviously, the TRi Ri thing is still in limbo, but its resolution involves the release of more shares; maybe that's on hold until SLE decides to relist and define its share price. How many shares is of interest, but considering Tosca Funds domininant oposition, it shouldn't be of much concern (I hope) to us small fry, as Tosca obviously invested in the expectation of a substantial return. Small investors have been marginalised in other companies' transitions in the past and it can happen again, but I'm hopefull that this won't be the case.

As far as I can see, it's now just in the waiting, waiting, the endless waiting.

Hopefully a positive resolution is in the offing.

(This is like the days of the tech boom, remember then?)

" transfer of 9.6 million shares"

This is the crux isn't it? Mart Western (or it's owners) are arguing that the value of these shares far outweighs the original debt, which may be irrelevant depending on how the original deal was set up, be it based on a mentary value at the time, or more crucially on a number of shares of equiv ilant value at that time. If the latter than, they they (MW) don't have a leg to stand on.

Nothing published on it so far...

https://www.africaintelligence.com/west-africa/2026/01/27/irish-junior-san-leon-energy-attempts-to-recover-oml-18,110612430-art

Just occurred to me that the previous RNS said that books would done after the deal was done; books are done, less auditing, so does that mean that the deal is done, or about to be finalised? It was originally stated that the deal was expected to be closed by Christmas, so are we to expect a second Christmas soon?

Top and bottom are mere reflecting the confusion in the GFM share price universe. These signs have usually held true on my experience. No reason to disavow your own perspective on things. My concern just now is how much of the new mine works is factored in. Part of me is convinced that a new price regime is in the offing, i.e. a significant rerating, but the current worldwide political state is not just putting a damper on things, but threatening a collapse. That said China is thriving despite Trump's efforts, possibly bringing about more steel consumption. I'm still on a strong buy.

Looks like the hurdle has been cleared (I do believe the future's a given, but geo-political events are the great dark horse today). What we have now is a double bottom, which suggests a launch point for a price regime. Last chance for a buy at low prices?

This bodes ill.We know the next news can only be good. Someones playing silly beggars with us. Triple top is usually followed by a plunging share price. If it happens, strong buying opportunity.

Note from yesterday's RNS, Spreadex has now become, potentially, Griffin's largest individual shareholder, at (potentially) 3%. Spreadex is a spread betting company. Someone's betting big sums on Griffin; are they betting on them rising or falling significantly? Big question. GFM has always delivered on production, but not on share price. Surely the price isn't going to crash at this point.

Hmm. Possibly not. One explanation is that the listing is a historical one, but it just popped up in a google search. not even an AI search, which has never happened before. Another explanation is that it's a trial run for a bigger event. It's quoting TTM (trailing twelve months) income of just under 6m, and operating income of -4m. I'd like to know how long the listing has been there for. I won't be parking on it.

The above link is quoting 8 trades in San Leon. Current price 0.3 (I assume USD) and a market cap of 134.974M (no currency quoted). OTCPK appears to be a here today, gone tomorrow trading board with minimal requirements for companyregistration. Is this work going on in the background? Has a deal been made?

Https://uk.finance.yahoo.com/quote/SLGYF/

"OTC Markets OTCPK - Delayed Quote

USD"

From Google:

"OTCPK" refers to a ticker symbol followed by ".PK," which indicates a stock is traded on the OTC Pink Market (formerly Pink Sheets), a type of over-the-counter (OTC) market. OTC markets trade securities not listed on major exchanges like the NYSE or NASDAQ, and they have significantly less regulation, disclosure requirements, and oversight than major exchanges, making them riskier. These markets are decentralized and use market makers to facilitate trades directly between parties.

Key characteristics of OTC markets

Decentralized trading: Trades occur directly between parties, often with the help of a broker-dealer network, rather than on a centralized exchange.

Lower regulatory oversight: There are fewer listing and reporting requirements compared to major stock exchanges like the NYSE or NASDAQ.

Disingenuous to suggest SLE doesn't care about its shareholders. Toscafund is its shareholder, and in reality its owner. We're nothing more than seagulls chasing the trawler hoping for something tasty to be thrown to them (remember that chestnut?).

It's only a win by default. With the Tram guy claiming he was impersonated, the media is possibly playing it hands off. Does anyoe know where the court case was supposed to take place? There should be a comment on the court records page, at least to say judgement deferred or hearing postponed.